THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- CGEMCullinan Therapeutics, IncRegulation FD disclosure and other events.−21.4%8-K 7.01 ↗
- FTHFaeth Therapeutics, IncRegulation FD disclosure.
Data support advancement of PIKTOR development into a Phase 3 registrational trial • Webcast today at 8 a.m. ET
−64.3%8-K 7.01 ↗ - FACTFACT II Acquisition CorpOther events.+0.5%8-K 8.01 ↗
- ROIVRoivant Sciences LtdResults of operations.−0.6%8-K 2.02 ↗
- AIOTPowerfleet, IncResults of operations and Regulation FD disclosure.
Affirm guidance for FY2027.
−30.1%8-K 2.02 ↗ - TNGXTango Therapeutics, IncResults of operations.+1.1%8-K 2.02 ↗
- BRCBrady CorpOfficer or director change.
Brady Corporation Strengthens Board with Finance and Technology Leaders Scott J. Robinson and Kenneth J. Spangler
−5.7%8-K 5.02 ↗ - SGCSuperior Group of Companies, IncResults of operations.
SUPERIOR GROUP OF COMPANIES REPORTS THIRD QUARTER 2026 RESULTS • Total net sales of $146.0 million, up 5% over prior year third quarter • Net income of $2.6 million versus $2.7 million in prior year…
+4.4%8-K 2.02 ↗ - AKAMAkamai Technologies IncMaterial agreement and other events.
Akamai Announces Proposed Offering of Convertible Senior Notes
+2.4%8-K 1.01 ↗ - IMVTImmunovant, IncResults of operations.+4.1%8-K 2.02 ↗
- OCULOcular Therapeutix, IncResults of operations.−15.5%8-K 2.02 ↗
- HAINHain Celestial Group IncResults of operations.
Hain Celestial Reports Fiscal First Quarter 2027 Financial Results Final required regulatory approvals received for the sale of the Company’s International business
−30.7%8-K 2.02 ↗ - CEVACeva IncResults of operations.
Ceva, Inc. Announces Third Quarter 2026 Financial Results 18% sequential royalty revenue growth and record AI licensing revenues, with multi-year smartphone modem ramp ahead
−17.3%8-K 2.02 ↗ - ZURAZura Bio LtdOther events.−77.2%8-K 8.01 ↗
- AMGAffiliated Managers Group, IncResults of operations and other events.+1.4%8-K 2.02 ↗
- FHTXFoghorn Therapeutics IncResults of operations and Regulation FD disclosure.−8.0%8-K 2.02 ↗
- WTTRSelect Water Solutions, IncResults of operations.−7.5%8-K 2.02 ↗
- AURAAura Biosciences, IncResults of operations and other events.
Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights Phase 3 CoMpass trial on track for topline data in 2H 2027; all participants have completed treatment…
+4.7%8-K 2.02 ↗ - VFFVillage Farms International, IncResults of operations.−30.2%8-K 2.02 ↗
- EDITEditas Medicine, IncResults of operations.−36.2%8-K 2.02 ↗
- TGTXTG Therapeutics, IncResults of operations.+5.9%8-K 2.02 ↗
- NWSNews CorpOther events.−3.8%8-K 8.01 ↗
- NRGNRG Energy, IncRegulation FD disclosure.−0.6%8-K 7.01 ↗
- PRAXPraxis Precision Medicines, IncResults of operations.+8.2%8-K 2.02 ↗
- GCMGGCM Grosvenor IncResults of operations.
GCM Grosvenor Reports Third Quarter 2026 Earnings Results With GAAP Net Income up 17%, Fee-Related Earnings Up 15%, and Adjusted Net Income Up 20% Year-Over-Year
−0.4%8-K 2.02 ↗ - VRTSVirtus Investment Partners, IncResults of operations.
Virtus Investment Partners Announces Financial Results for Third Quarter 2026 ▪ Earnings Per Share - Diluted of $3.26; Earnings Per Share - Diluted, as Adjusted, of $5.86 ▪ Total Sales of $4.3B; Net…
−20.7%8-K 2.02 ↗ - DTILPrecision Biosciences IncOther events.−30.2%8-K 8.01 ↗
- PROKProkidney CorpResults of operations and Regulation FD disclosure.−8.8%8-K 2.02 ↗
- ISPRIspire Technology IncResults of operations.−20.6%8-K 2.02 ↗
- IONSIonis Pharmaceuticals IncResults of operations.−32.6%8-K 2.02 ↗
- WDWalker & Dunlop, IncRegulation FD disclosure.+1.3%8-K 7.01 ↗
- TTRXTurn Therapeutics IncResults of operations.
Building on GX-03 Momentum, Turn Therapeutics Accelerates Hidradenitis Suppurativa Trial with Enrollment Now Expected to Begin in First Quarter 2027 Former CDC Director Robert R. Redfield, M.D…
−14.6%8-K 2.02 ↗ - NVCRNovoCure LtdRegulation FD disclosure.
Novocure Provides Regulatory Update on U.S. FDA Premarket Approval Application for Optune Mya® for Brain Metastases from Non-Small Cell Lung Cancer
−19.4%8-K 7.01 ↗ - VIAVia Transportation, IncResults of operations.+21.4%8-K 2.02 ↗
- FLUTFlutter Entertainment plcThe Chief Financial Officer sold $82K of stock.$82K−17.8%Form 4 ↗
- FLUTFlutter Entertainment plcThe Chief Executive Officer sold $307K of stock.$307K−17.8%Form 4 ↗
- CEGConstellation Energy CorpResults of operations and Regulation FD disclosure.−4.9%8-K 2.02 ↗
- KKRKKR & Co. IncResults of operations.
KKR & Co. Inc. Reports Third Quarter 2026 Financial Results November 9, 2026
−8.0%8-K 2.02 ↗ - THTarget Hospitality CorpResults of operations.
Target Hospitality Announces Third Quarter 2026 Results Reflecting Execution at Scale and Building Momentum on Continued Strategic Transformation Since January 2026, secured over $1.7 billion of…
−1.6%8-K 2.02 ↗ - FERGFerguson Enterprises IncResults of operations.+3.0%8-K 2.02 ↗
- WAFDWafd IncOfficer or director change.−9.2%8-K 5.02 ↗
- LDIloanDepot, IncResults of operations and Regulation FD disclosure.−45.3%8-K 2.02 ↗
- NRGNRG Energy, IncResults of operations.−0.6%8-K 2.02 ↗
- CNHCNH Industrial N.V.Regulation FD disclosure.−7.1%8-K 7.01 ↗
- SGISomnigroup International IncResults of operations and other events.
SGI ANNOUNCES THIRD QUARTER 2026 RESULTS SOMNIGROUP INTERNATIONAL INC. REPORTS RECORD THIRD QUARTER 2026 RESULTS - Third Quarter Net Sales increased 11% to $2.4 Billion - Third Quarter GAAP EPS of…
−9.9%8-K 2.02 ↗ - ABEOAbeona Therapeutics IncResults of operations and Regulation FD disclosure.−42.0%8-K 2.02 ↗
- SOCSable Offshore CorpResults of operations and Regulation FD disclosure.
Sable Offshore Corp. Reports Third Quarter 2026 Financial and Operational Results
−73.1%8-K 2.02 ↗ - SEATVivid Seats IncResults of operations.
Vivid Seats Reports Third Quarter 2026 Results Enters new era with a return to GOV and EBITDA growth
−25.4%8-K 2.02 ↗ - IBRXImmunityBio, IncRegulation FD disclosure.−30.3%8-K 7.01 ↗
- KGSKodiak Gas Services, IncResults of operations.
Kodiak Gas Services Reports Third Quarter 2026 Financial Results, Increases Full Year 2026 Adjusted EBITDA and Discretionary Cash Flow Guidance
−3.7%8-K 2.02 ↗